(Q40446287)

English

Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Zac Varghese

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ray Fernando

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

John F Moorhead

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Stephen H Powis

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Xiong Z Ruan

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

15 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

289

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

F43-8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Atherosclerosis. Scavenging for receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E-Deficient Mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Tailoring immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Rapamycin resistance tied to defective regulation of p27Kip1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Long-term survival in renal transplant recipients with graft function

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Inflammation modifies lipid-mediated renal injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Human mesangial cells express inducible macrophage scavenger receptor

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Rapamycin: a novel immunosuppressive macrolide

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Stable cell lines of T-SV40 immortalized human glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Immunologic and nonimmunologic correlates of chronic renal allograft dysfunction

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Glomerular foam cells in kidney allograft

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00181.2004

21 January 2018

Identifiers

10.1152/AJPRENAL.00181.2004

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40446287&oldid=1898058990"